Wide Ranks

DVAX

Dynavax Technologies Corporatio

12.91

Top Statistics
Market Cap 1 B Forward PE 38.54 Revenue Growth 16.00 %
Current Ratio 13.23 Trailing PE 86.07 Earnings Growth 20.80 %
Profit Margins 7.85 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -731.78 Enterprise / Revenue 4.55 Price To Sales Trailing12 Months 6.51
Profitability
Profit Margins 7.85 % Operating Margins 15.24 %
Balance Sheet
Total Cash 763 M Total Cash Per Share 5.81 Total Debt 254 M
Total Debt To Equity 37.36 Current Ratio 13.23 Book Value Per Share 5.19
All Measures
Short Ratio 676.00 % Message Board Id finmb_423490 Fax 510 848 1327
Shares Short Prior Month 17 M Return On Equity 0.0318 City EmeryVille
Uuid 1098d91b-0224-393f-80a2-54d47c7c6e9b Previous Close 12.66 First Trade Date Epoch Utc 1 B
Book Value 5.19 Beta 1.34 Total Debt 254 M
Volume 1 M Price To Book 2.49 Last Split Date 1 B
Fifty Two Week Low 9.74 Total Cash Per Share 5.81 Total Revenue 260 M
Shares Short Previous Month Date 1 B Target Median Price 25.00 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins 15.24 % Target Mean Price 24.60
Net Income To Common 20 M Short Percent Of Float 0.1950 Implied Shares Outstanding 131 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 2 M
Average Volume10days 2 M Total Cash 763 M Next Fiscal Year End 1 B
Revenue Per Share 2.00 Held Percent Insiders 0.0034 Ebitda Margins -0.62 %
Trailing PE 86.07 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 12.66 Target Low Price 15.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 11.59 Open 12.73 Free Cashflow 12 M
State CA Dividend Yield 0.00 % Return On Assets -0.0038
Time Zone Short Name EST Trailing Eps 0.1500 Day Low 12.67
Address1 2100 Powell Street Shares Outstanding 131 M Price Hint 2
Target High Price 29.00 Website https://www.dynavax.com 52 Week Change -0.0577
Average Volume 2 M Earnings Quarterly Growth 23.10 % Forward Eps 0.3600
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 1199.50 %
Last Split Factor 1:10 Regular Market Day High 12.99 Is_sp_500 False
Profit Margins 7.85 % Debt To Equity 37.36 Fifty Two Week High 15.01
Day High 12.99 Shares Short 20 M Regular Market Open 12.73
Industry Key drug-manufacturers-specialty-generic Earnings Growth 20.80 % Enterprise To Revenue 4.55
Revenue Growth 16.00 % Shares Percent Shares Out 0.1597 Operating Cashflow 27 M
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 94608 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name Dynavax Technologies Corporation Regular Market Day Low 12.67
Held Percent Institutions 1.05 Current Price 12.91 Address2 Suite 720
Enterprise To Ebitda -731.78 Financial Currency USD Current Ratio 13.23
Gross Margins 62.09 % Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 5
Country United States Float Shares 113 M Two Hundred Day Average 11.59
Ir Website http://investors.dynavax.com/index.cfm Enterprise Value 1 B Price To Sales Trailing12 Months 6.51
Forward PE 38.54 Regular Market Volume 1 M Ebitda -1623000
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States.

It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.

The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B.

Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co.

, Limited; Biological E.

Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt.

Ltd.

The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.

The company was incorporated in 1996 and is headquartered in Emeryville, California.